1040 related articles for article (PubMed ID: 25632936)
21. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.
Zou H; Shao CX; Zhou QY; Zhu GQ; Shi KQ; Braddock M; Huang DS; Zheng MH
Expert Rev Gastroenterol Hepatol; 2016; 10(3):331-40. PubMed ID: 26558504
[TBL] [Abstract][Full Text] [Related]
22. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
Front Immunol; 2022; 13():847728. PubMed ID: 35281015
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
Giordano S; Columbano A
Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
[TBL] [Abstract][Full Text] [Related]
24. Functional long non-coding RNAs in hepatocellular carcinoma.
Xie C; Li SY; Fang JH; Zhu Y; Yang JE
Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
[TBL] [Abstract][Full Text] [Related]
25. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA network: Novel insight into hepatocellular carcinoma metastasis (Review).
Zhu X; Pan H; Liu L
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34013360
[TBL] [Abstract][Full Text] [Related]
27. Role of miRNA sponges in hepatocellular carcinoma.
Li D; Zhang J; Li J
Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs.
Amicone L; Citarella F; Cicchini C
Biomed Res Int; 2015; 2015():473942. PubMed ID: 25861629
[TBL] [Abstract][Full Text] [Related]
29. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
Bao H; Su H
Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNAs: critical players in hepatocellular carcinoma.
Sun J; Bie B; Zhang S; Yang J; Li Z
Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
[TBL] [Abstract][Full Text] [Related]
32. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
[TBL] [Abstract][Full Text] [Related]
33. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.
Parasramka MA; Maji S; Matsuda A; Yan IK; Patel T
Pharmacol Ther; 2016 May; 161():67-78. PubMed ID: 27013343
[TBL] [Abstract][Full Text] [Related]
35. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
36. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract][Full Text] [Related]
37. The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.
Lanzafame M; Bianco G; Terracciano LM; Ng CKY; Piscuoglio S
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495592
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
[TBL] [Abstract][Full Text] [Related]
39. Targeting non-coding RNAs and N
Wu L; Zhang Y; Ren J
Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]